Editas Medicine, Inc. (EDIT)
NASDAQ·Healthcare·Biotechnology
$2.62
+10.81%
Mkt Cap $240.84M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (20 analysts)
$5.00
Range $4.00 – $6.00
Implied Upside
+91.2%
Consensus $5.00 vs current $2.62
NASDAQ·Healthcare·Biotechnology
$2.62
+10.81%
Mkt Cap $240.84M
Buy
3
Hold
0
Sell
0
Price Target (20 analysts)
$5.00
Range $4.00 – $6.00
+91.2%
Consensus $5.00 vs current $2.62